TNFSF10 and soft tissue sarcoma: Although the different functions exerted by the soluble form and membrane-bound version of TRAIL in different contexts require further investigation, it has, however, been shown that soluble TRAIL can exert angiogenic activity in soft tissue sarcomas [151].